{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T13:45:51Z","timestamp":1767707151112},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 66-year-old man with neuroendocrine tumor originating from midgut was referred to <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT imaging for restaging postoperatively. No suspicious uptake regarding residual primary tumoral involvement was seen. But there was diffuse high uptake in prostate gland suggestive of prostatitis or secondary primary tumoral lesion. Concurrent prostate-specific antigen level was 5.02 ng\/mL (range, 0\u20134 ng\/mL), C-reactive protein level was 8.25 mg\/L (range, &lt;5 mg\/L), and white blood cell count was 6.83 \u00d7 10<jats:sup>3<\/jats:sup>\/\u03bcL (range, 3.9\u201310.9 \u00d7 10<jats:sup>3<\/jats:sup>\/\u03bcL). Diagnosis of active chronic prostatitis was achieved by core biopsy, which is identified as potential cause for false-positive diffuse uptake on <jats:sup>68<\/jats:sup>Ga-DOTATATE PET\/CT.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002594","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T07:35:02Z","timestamp":1555313702000},"page":"e499-e500","source":"Crossref","is-referenced-by-count":6,"title":["False-Positive 68Ga-DOTATATE PET\/CT in Active Chronic Prostatitis"],"prefix":"10.1097","volume":"44","author":[{"given":"Burcak","family":"Yilmaz","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, Istanbul Research and Training Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilal Serap","family":"Arslan","sequence":"additional","affiliation":[{"name":"Pathology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cihan","family":"Gundogan","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Istanbul Research and Training Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Nuri","family":"Gunes","sequence":"additional","affiliation":[{"name":"Urology Department, Kanuni Sultan Suleyman Research and Training Hospital, Health Sciences University, Istanbul, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tevfik Fikret","family":"Cermik","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Istanbul Research and Training Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"bib1-20230925","first-page":"2806","article-title":"Somatostatin receptors in human prostate and prostate cancer","volume":"80","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1097\/RLU.0000000000001100","article-title":"Spectrum of 68Ga-DOTA TATE uptake in patients with neuroendocrine tumors","volume":"41","year":"2016","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1097\/MNM.0b013e32833f635e","article-title":"Distribution pattern of 68Ga-DOTATATE in disease-free patients","volume":"31","year":"2010","journal-title":"Nucl Med Commun"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1097\/RLU.0b013e31822920c9","article-title":"In vivo visualization of somatostatin receptor expression with Ga-68-DOTA-TATE PET\/CT in advanced metastatic prostate cancer","volume":"36","year":"2011","journal-title":"Clin Nucl Med"},{"key":"bib5-20230925","first-page":"5805s","article-title":"Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by 111In-labeled DTPA-D-Phe1-octreotide scintigraphy","volume":"55","year":"1995","journal-title":"Cancer Res"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2967\/jnumed.110.077941","article-title":"Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline","volume":"52","year":"2011","journal-title":"J Nucl Med"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11307-009-0230-3","article-title":"Visualization of somatostatin receptors in prostate cancer and its bone metastases with Ga-68-DOTATOC PET\/CT","volume":"12","year":"2010","journal-title":"Mol Imaging Biol"},{"key":"bib8-20230925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0000000000001424","article-title":"PET\/CT With 68Ga-DOTA-TATE for diagnosis of neuroendocrine: differentiation in patients with castrate-resistant prostate cancer","volume":"42","year":"2017","journal-title":"Clin Nucl Med"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MNM.0000000000000668","article-title":"Clinical significance of incidental prostatic fluorine-18-fluorodeoxyglucose uptake in the diagnosis of infectious prostatitis in adult males","volume":"38","year":"2017","journal-title":"Nucl Med Commun"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13139-015-0364-y","article-title":"Granulomatous prostatitis after intravesical bacillus Calmette-Gu\u00e9rin instillation therapy: a potential cause of incidental F-18 FDG uptake in the prostate gland on F-18 FDG PET\/CT in patients with bladder cancer","volume":"50","year":"2016","journal-title":"Nucl Med Mol Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201908000-00032","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T05:04:38Z","timestamp":1695618278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201908000-00032"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002594","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,15]]}}}